S
1.35
0.02 (1.50%)
| Penutupan Terdahulu | 1.33 |
| Buka | 1.27 |
| Jumlah Dagangan | 109,757 |
| Purata Dagangan (3B) | 310,234 |
| Modal Pasaran | 2,164,434 |
| Harga / Buku (P/B) | 1.84 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -69.25 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 33.61% |
| Nisbah Semasa (MRQ) | 2.78 |
| Aliran Tunai Operasi (OCF TTM) | -8.62 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.73 M |
| Pulangan Atas Aset (ROA TTM) | -115.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -346.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
| Stok | Shuttle Pharmaceuticals Holding | - | - |
AISkor Stockmoo
0.9
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.88 |
|
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| % Dimiliki oleh Orang Dalam | 5.82% |
| % Dimiliki oleh Institusi | 0.84% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 21 Nov 2025 | Pengumuman | Shuttle Pharmaceuticals Acquires AI Health Platform |
| 03 Nov 2025 | Pengumuman | Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00 |
| 22 Oct 2025 | Pengumuman | Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH) |
| 22 Oct 2025 | Pengumuman | Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH) |
| 21 Oct 2025 | Pengumuman | Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH) |
| 21 Oct 2025 | Pengumuman | Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform |
| 10 Oct 2025 | Pengumuman | Shuttle Executes LOI with Molecule.ai |
| 09 Oct 2025 | Pengumuman | Shuttle to Enter $3.24 Billion AI Pharmaceutical Market |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |